Abstract
This study projected for environmental impact driven by the pharmaceutical activity on regional biological environment quality. This Environmental Impact Assessment (EIA) study based on one season primary environmental quality data, environmental impact statement based on the identification, prediction, and evaluation of impact. Detailed studies were carried out about biological components of the environment in the study area of 7 km radial distance from Usgaon as a central point. The paper is dealing with, Study of the biological environment includes the topography, the vegetation type and the flora and fauna of the region along with crops for prediction of impacts due to the existing pharmaceutical effluents and bulk drugs at Marvasodo, Usgaon, and Phonda (Goa).
Highlights
The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology (Kumar & Sharan, 2013)
The percentage of medicinal plant species for these observations is about 45%
The highest index of diversity was recorded at Usgaon village
Summary
The Indian Pharmaceutical Industry today is in the front rank of India’s science-based industries with wide ranging capabilities in the complex field of drug manufacture and technology (Kumar & Sharan, 2013). A highly organized sector, the Indian Pharma Industry is estimated to be worth $ 4.5 billion, growing at about 8 to 9 percent annually. It ranks very high in the third world, in terms of technology, quality, and range of medicines manufactured. The Indian Pharmaceutical sector is highly fragmented with more than 20,000 registered units. The leading 250 pharmaceutical companies control 70% of the market with market leader holding nearly 7% of the market share. It is an extremely fragmented market with severe price competition and government price control. It is an extremely fragmented market with severe price competition and government price control. (WP1; WP3– WP5)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
